ALCOHOL-WITHDRAWAL - WHAT IS THE BENZODIAZEPINE OF CHOICE

被引:39
作者
BIRD, RD
MAKELA, EH
机构
[1] W VIRGINIA UNIV,SCH MED,DEPT CLIN PHARM,MORGANTOWN,WV 26506
[2] W VIRGINIA UNIV,SCH MED,DEPT BEHAV MED & PSYCHIAT,MORGANTOWN,WV 26506
关键词
D O I
10.1177/106002809402800114
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the literature concerning the use of benzodiazepines for treatment of alcohol withdrawal and to determine if the current literature assessment justifies the use of lorazepam as first-line therapy. DATA SOURCES: A thorough review of the literature was performed with an online database (BRS Colleague). Articles directed at the targeted issue were chosen and additional references were obtained from the bibliographies of these articles. STUDY SELECTION: Clinical trials and case reports concerning the use of chlordiazepoxide, diazepam, and lorazepam in alcohol withdrawal treatment were reviewed. DATA SYNTHESIS: Lorazepam is considered by many to be the drug of choice for alcohol withdrawal because it undergoes glucuronidation and has an intermediate half-life. These characteristics have suggested its superiority when treating elderly patients or patients with liver disease. However, some studies suggest that a drug with a longer half-life would provide smoother withdrawal. In addition, the number of patients with liver disease treated for alcohol withdrawal is unknown. These and other factors question the recommendation of lorazepam as the drug of choice. CONCLUSIONS: Well-controlled comparison studies should be performed before recommending the routine use of lorazepam for treating alcohol withdrawal syndrome.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 22 条
  • [1] Alpert M A, 1985, Mo Med, V82, P79
  • [2] THE ALCOHOL WITHDRAWAL SYNDROME
    BROWN, CG
    [J]. ANNALS OF EMERGENCY MEDICINE, 1982, 11 (05) : 276 - 280
  • [3] ALCOHOLIC LIVER-DISEASE
    DIEHL, AM
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1989, 73 (04) : 815 - 830
  • [4] Engle J P, 1988, Am Pharm, VNS28, P51
  • [5] GREENBLATT D, 1987, PSYCHOPHARMACOLOG S3, P62
  • [6] CLINICAL PHARMACOKINETICS OF OXAZEPAM AND LORAZEPAM
    GREENBLATT, DJ
    [J]. CLINICAL PHARMACOKINETICS, 1981, 6 (02) : 89 - 105
  • [7] GREENBLATT DJ, 1983, NEW ENGL J MED, V309, P410
  • [8] CLINICAL PHARMACOKINETICS OF CHLORDIAZEPOXIDE
    GREENBLATT, DJ
    SHADER, RI
    MACLEOD, SM
    SELLERS, EM
    [J]. CLINICAL PHARMACOKINETICS, 1978, 3 (05) : 381 - 394
  • [9] ABSORPTION OF ORAL AND INTRAMUSCULAR CHLORDIAZEPOXIDE
    GREENBLATT, DJ
    SHADER, RI
    MACLEOD, SM
    SELLERS, EM
    FRANKE, K
    GILES, HG
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 13 (04) : 267 - 274
  • [10] GREENBLATT DJ, 1981, BR J CLIN PHARM, V11, P11